| Goods and Services | Pharmaceutical preparations for treating skin disorders; Pharmaceutical preparations for treating epidermal problems; Pharmaceutical preparations for the treatment of generalized pustular psoriasis (GPP); Pharmaceutical preparations for the treatment of a disease or disorder that is responsive to IL-36R inhibition or neutralization, namely, a disease or disorder in which a
decrease in IL-36R levels or activity has a therapeutic benefit; Pharmaceutical preparations for the treatment of a disease or disorder that is responsive to IL-
36R inhibition or neutralization, namely, a disease or disorder in which the
improper expression or increased activity of IL-36R causes or contributes to
the pathological effects of the disease or disorder; Pharmaceutical preparations for the treatment of a disease or disorder that is responsive to IL-
36R inhibition or neutralization, namely, inflammatory diseases,
autoimmune diseases, respiratory diseases, metabolic disorders, and
cancer; Pharmaceutical preparations for the treatment of an inflammatory
disorder, namely, allergic inflammation of the skin, lungs, and
gastrointestinal tract, atopic dermatitis or atopic eczema, allergic asthma
and non-allergic asthma, epithelial-mediated inflammation, fibrosis,
idiopathic pulmonary fibrosis, scleroderma, kidney fibrosis, scarring,
allergic rhinitis, food allergies, seasonal allergies, and other allergies; Pharmaceutical preparations for the treatment of an autoimmune disease,
namely, multiple sclerosis, asthma, type 1 diabetes mellitus, rheumatoid
arthritis, scleroderma, Crohn's disease, psoriasis vulgaris or psoriasis,
pustular psoriasis, generalized pustular psoriasis (GPP), palmo-plantar
pustulosis (PPP), inflammatory bowel disease, psoriatic arthritis, multiple
sclerosis, rheumatoid arthritis, systemic lupus erythematosus (SLE),
ulcerative colitis, and ankylosing spondylitis; Pharmaceutical preparations for the treatment of a respiratory disease, namely, asthma, cystic fibrosis,
emphysema, chronic obstructive pulmonary disease (COPD), and acute
respiratory distress syndrome; Pharmaceutical preparations for the treatment of a metabolic disorder, namely, obesity, type 2 diabetes, atherosclerosis, and cardiovascular disease; Pharmaceutical preparations for the treatment of cancer, namely, melanoma, renal cell carcinoma, lung cancer, bladder
cancer, breast cancer, cervical cancer, colon cancer, gall bladder cancer,
laryngeal cancer, liver cancer, thyroid cancer, stomach cancer, salivary
gland cancer, prostate cancer, pancreatic cancer, leukemia, lymphoma, and
Merkel cell carcinoma; Pharmaceutical preparations for the treatment of a
chronic skin condition, namely, hidradenitis suppurativa; Pharmaceutical preparations for the treatment of immune system related diseases and disorders; Pharmaceutical preparations and substances for the treatment of damaged skin and tissue |
